Evidence map›Paper›PMID 32649861›Full record

ReviewDevelopmental cell2020

Exaptive Evolution of Target of Rapamycin Signaling in Multicellular Eukaryotes.

Jacob O Brunkard

Open access · bronzeAbstract readReview
In one paragraph

Review in Developmental cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Functional analysis of target of rapamycin in regulating mycelial growth and development in Penicillium italicum.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Plant signaling & behavior · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Genetic suppressor ofFrontiers in plant science · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jacob O BrunkardDepartment of Plant and Microbial Biology, University of California at Berkeley, Berkeley, CA 94720, USA; Plant Gene Expression Center, U.S. Department of Agriculture Agricultural Research Service, Albany, CA 94710, USA; Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: brunkard@berkeley.edu.
Agricultural Research Service · US

Funding

An aminoacyl tRNA synthetase is a nitrogen sensor that activates TOR in plantsDP5OD023072 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI BRUNKARD, JACOB O · 2016 to 2020
$1.6M
NIH HHS DP5 OD023072
6 · The paper itself

Abstract

Target of rapamycin (TOR) is a protein kinase that coordinates metabolism with nutrient and energy availability in eukaryotes. TOR and its primary interactors, RAPTOR and LST8, have been remarkably evolutionarily static since they arose in the unicellular last common ancestor of plants, fungi, and animals, but the upstream regulatory mechanisms and downstream effectors of TOR signaling have evolved considerable diversity in these separate lineages. Here, I focus on the roles of exaptation and adaptation in the evolution of novel signaling axes in the TOR network in multicellular eukaryotes, concentrating especially on amino acid sensing, cell-cell signaling, and cell differentiation.

Indexed as

Amino AcidsAnimalsEukaryotaSignal TransductionSirolimusTOR Serine-Threonine KinasesAmino AcidsSirolimusTOR Serine-Threonine KinasesevolutionexaptationmetabolismmTORmulticellularitynutrient sensingPIKKsplasmodesmataribosome biogenesistarget of rapamycin

Identifiers

PMID32649861
PMCPMC7346820
OpenAlexW3041770412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.